UK Covid: Van-Tam says AstraZeneca vaccine’s risk v benefit is finely balanced for younger people – as it happened

Deputy chief medical officer says benefits for older age groups clear, but adults under 30 should be offered an alternative to AstraZeneca jab. This live blog is now closed - please follow the global live blog for coronavirus updates

• Under-30s in UK should be offered alternative to AstraZeneca jab
• Under-30s may have small delay' in getting Covid jab, says Van-Tam
• Risks v benefits of Oxford/AstraZeneca vaccine by age group
• Rare blood clot risk after AZ jab about four cases per million, says MHRA
• Third of severe Covid survivors diagnosed with mental health condition
• Only 3% of SNP supporters would back Alba party, poll suggests

6.06pm BST

But you can see that at a very low exposure risk ... the risk-benefit is relatively finely balanced in those younger age groups.

Over 1 in 10 adults have now been fully vaccinated across the UK

I want to thank the whole team involved - the NHS, armed forces, councils, scientists, volunteers, pharmacists & the British public.

This is a mammoth team effort. pic.twitter.com/kslub4kQQU

Related: Coronavirus live: EMA finds possible link between AZ jab and rare blood clots; record cases in France ICUs

5.27pm BST

The UK has recorded 45 further coronavirus deaths and 2,763 new cases, according to the latest update to the government's dashboard.